Laurus Labs has allotted 193,456 equity shares under ESOS on 28 May 2024. With this allotment, the paid up equity share capital has increased to Rs.107,83,18,628/-. Powered by Capital Market - Live News

Laurus Labs announced that the 19th Annual General Meeting (AGM) of the company will be held on 11 July 2024.Powered by Capital Market - Live News

Net profit of Laurus Labs declined 26.58% to Rs 75.61 crore in the quarter ended March 2024 as against Rs 102.98 crore during the previous quarter ended March 2023. Sales rose 4.26% to Rs 1439.67 crore in the quarter ended March 2024 as against Rs 1380.90 crore during the previous quarter ended March 2023.For the full year,net profit declined 79.68% to Rs 160.55 crore in the year ended March 2024 as against Rs 790.11 crore during the previous year ended March 2023. Sales declined 16.55% to Rs 5040.83 crore in the year ended March 2024 as against Rs 6040.55 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales1439.671380.90 4 5040.836040.55 -17 OPM %16.7720.68 -15.4226.36 - PBDT209.52234.15 -11 620.941433.02 -57 PBT107.27147.14 -27 236.361108.94 -79 NP75.61102.98 -27 160.55790.11 -80 Powered by Capital Market - Live News

Laurus Labs announced that the Board of Directors of the Company at its meeting held on 25 April 2024, has recommended a Second Interim dividend of Rs.0.40 per share (i.e.20%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Laurus Labs will hold a meeting of the Board of Directors of the Company on 25 April 2024.Powered by Capital Market - Live News